Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers

Initiation of phase 1 portion of the trial planned in 2H 2026-Phase 2 portion of the trial will initiate development of the elraglusib tablet in ...
Zacks Investment Research on MSN

TEVA signs deal with RPRX to accelerate development of vitiligo drug

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up ...
Newsfirst.lk

75 Additional Rural Roads Slated for Development Under Second Phase of RDA Project

The Road Development Authority (RDA) announced plans to develop 75 additional roads under the second phase of the Rural Road ...
SpaceNews

NASA releases details on revised next phase of commercial space station development

WASHINGTON — NASA expects to spend up to $1.5 billion to support at least two companies to demonstrate crew-tended space stations as part of the agency’s revised approach to transition from the ...